1 Keiser O, Giudici F, Mullhaupt B, Junker C, Dufour JF, Moradpour D, et al. Trends in hepatitis C-related mortality in Switzerland. J Viral Hepat. 2018;25(2):152–60.
2 WHO. Global Health Sector Strategy on Viral Hepatitis 2016–2021. Geneva: World Health Organization, 2016. Contract No.: WHO/HIV/2016.06.
3 Network SHS. Swiss Hepatitis Strategy 2014–2030: It’s time to act now. Process Paper – A Living Document. Zurich: Swiss Hepatitis, 2019.
4 Mullhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, et al. Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030? PLoS One. 2018;13(12):e0209374.
5 Müller D. Interpellation 19.3042: Mittel des Bundes für die Bekämpfung von viraler Hepatitis. Bern.
6 Bregenzer A, Conen A, Knuchel J, Friedl A, Eigenmann F, Naf M, et al. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade. Swiss Med Wkly. 2017;147:w14544.
7 European Association for the Study of the Liver (EASL). EASL Policy Statement on Hepatitis C Elimination. 2019.
https://easl.eu/wp-content/uploads/2019/04/EASL-Policy-Statement-on-Hepatitis-C-Elimination.pdf
8 WHO. Action plan for the health sector response to viral hepatitis in the WHO European Region. Copenhagen: WHO Regional Office for Europe, 2017.
9 German Federal Ministry of Health. Integrated Strategy for HIV, Hepatitis B and C and Other Sexually Transmitted Infections. Berlin: 2016.
10 ANRS (Agence nationale de recherche sur le sida et les hépatites virales): the renowned French research institute ARNS, originally founded to fight the HIV epidemic, added viral hepatitis as focus already in 2005.
11 Müller D. Motion 19.3743: Die Eliminierung von Hepatitis gehört in ein Nationales Programm sexuell und blutübertragbarer Infektionskrankheiten.